Priti Hegde | Director And Global Franchise Lead

Priti Hegde, Director And Global Franchise Lead, Genentech

I have spent nearly 2 decades of my career in studying human cancer biology and mechanisms by which we can better tailor therapies for patients based on their tumor molecular fingerprints. Ever since joining Genentech in 2007, my interests have mostly been in studying the tumor microenvironment. In addition to studying markers associated with clinical benefit to anti-angiogenesis agents, my research interests now focus on biological mechanisms associated with efficacy or escape to immunotherapy agents in human cancers. Working at Genentech, we have the luxury of interrogating human tumor biology from large clinical trials that enable us to develop hypotheses that can be interrogated in humans in real time. I am currently Director and Global Franchise Lead for Cancer Immunotherapy Biomarkers. I lead a group of 20 individuals whose responsibilities include identifying diagnostic strategies for cancer immunotherapies, studying mechanisms of action of immunotherapy agents in patients and interrogating mechanisms associated with immune escape to enable smart combination strategies for patients with cancer.


December 2 Pre-Congress Workshops @ 13:00

Uses and clinical application of immune profiling assays for cancer:

The use of novel assays and computational methods to analyse the immune system is a very fast-moving field and it is challenging to keep up with the pace of change. Join our Advances in Immune Profiling Assays workshop on 2nd December for an in depth look at the uses and clinical application of new methods to characterise and profile the human immune system for the accelerated development of new therapies.Topics:·Measuring base-line immune function ·Assessing predictive biomarkers for PD1 / PDL1 immunotherapies·How to assess the efficacy and longevity of cellular therapies·Characterising the tumor microenvironment·Discovery of genomic predictors and genomic alterations that promote or suppress immune response·Discovery and development of novel biomarkers
last published: 20/Aug/19 15:45 GMT

back to speakers

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Oliver Breed
+44 (0)207 092 1156

To speak:
Lauren Sheppard
+44 (0)207 092 1211